NASDAQ:QDEL QuidelOrtho (QDEL) Stock Price, News & Analysis $10.74 +0.12 (+1.13%) Closing price 11/13/2026 04:00 PM EasternExtended Trading$10.74 0.00 (0.00%) As of 11/13/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About QuidelOrtho Stock (NASDAQ:QDEL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get QuidelOrtho alerts:Sign Up Key Stats Today's Range$10.28▼$11.1950-Day Range$10.34▼$14.3552-Week Range$9.92▼$35.58Volume2.04 million shsAverage Volume2.36 million shsMarket Capitalization$736.87 millionP/E RatioN/ADividend YieldN/APrice Target$13.63Consensus RatingReduce Company Overview QuidelOrtho Corporation develops and manufactures diagnostic testing products used in healthcare settings. Its offerings include tests and instruments for immunoassay, molecular diagnostics, clinical chemistry, and transfusion medicine, as well as rapid tests designed for point-of-care use. The company serves hospitals, clinical laboratories, blood banks, physician offices, and other healthcare providers. Its product lines include the VITROS clinical laboratory systems, ORTHO VISION blood-bank analyzers, and Sofia rapid diagnostic platforms. QuidelOrtho was formed through the combination of Quidel Corporation and Ortho Clinical Diagnostics, which completed their merger in 2022. The company serves customers in the United States and internationally.AI Generated. May Contain Errors. Read More QuidelOrtho Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks63rd Percentile Overall ScoreQDEL MarketRank™: 3.155269720435 of 5 starsQuidelOrtho scored higher than 63% of companies evaluated by MarketBeat, and ranked 332nd out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingReduce Consensus RatingQuidelOrtho has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 4 hold ratings, and 2 sell ratings.Upside PotentialQuidelOrtho has a consensus price target of $13.63, representing about 26.9% upside from its current price of $10.74.Amount of Analyst CoverageQuidelOrtho has only been the subject of 2 research reports in the past 90 days.Read more about QuidelOrtho's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth100.00% Earnings GrowthEarnings for QuidelOrtho are expected to grow by 100.00% in the coming year, from $0.66 to $1.32 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of QuidelOrtho is -1.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of QuidelOrtho is -1.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioQuidelOrtho has a P/B Ratio of 0.41. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted21.32% of the float of QuidelOrtho has been sold short.Short Interest Ratio / Days to CoverQuidelOrtho has a short interest ratio ("days to cover") of 7.6.Change versus previous monthShort interest in QuidelOrtho has recently increased by 11.34%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldQuidelOrtho does not currently pay a dividend.Dividend GrowthQuidelOrtho does not have a long track record of dividend growth. News and Social Media3.5 / 5News Sentiment0.52 News SentimentQuidelOrtho has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 9 news articles for QuidelOrtho this week, compared to 4 articles on an average week.Search Interest4 people have searched for QDEL on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat Follows1 people have added QuidelOrtho to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, QuidelOrtho insiders have not sold or bought any company stock.Percentage Held by Insiders1.10% of the stock of QuidelOrtho is held by insiders.Percentage Held by Institutions99.00% of the stock of QuidelOrtho is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about QuidelOrtho's insider trading history. Receive QDEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for QuidelOrtho and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. QDEL Stock News HeadlinesQuidelOrtho Earnings Call Signals Pressure and Profit Recovery32 minutes ago | tipranks.comDid QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?November 12 at 12:15 PM | prnewswire.comToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.November 15 at 1:00 AM | Behind the Markets (Ad)Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving QuidelOrtho (QDEL)November 12 at 10:10 AM | globenewswire.comQuidelOrtho Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of QuidelOrtho Corporation - QDELNovember 11, 2026 | businesswire.comQDEL SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving QuidelOrthoNovember 10, 2026 | prnewswire.comQuidelOrtho Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into QuidelOrtho (QDEL)November 9, 2026 | prnewswire.comQuidelOrtho (NASDAQ:QDEL) Stock Price Down 9.2% - What's Next?November 8, 2026 | americanbankingnews.comSee More Headlines QDEL Stock Analysis - Frequently Asked Questions How have QDEL shares performed this year? QuidelOrtho's stock was trading at $28.56 at the beginning of 2026. Since then, QDEL shares have decreased by 62.4% and is now trading at $10.74. How were QuidelOrtho's earnings last quarter? QuidelOrtho Corporation (NASDAQ:QDEL) released its quarterly earnings data on Tuesday, November, 3rd. The company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.18 by $0.13. QuidelOrtho's revenue for the quarter was down 11.6% on a year-over-year basis. Read the conference call transcript. Who are QuidelOrtho's major shareholders? Top institutional shareholders of QuidelOrtho include State Street Corp (4.41%), Private Management Group Inc. (3.34%), Gagnon Securities LLC (1.89%) and Skylands Capital LLC (0.85%). Insiders that own company stock include Brian J Blaser, Matthew Strobeck, Ann D Rhoads, Joseph D Jr Wilkins, Joseph M Busky and Carlyle Group Inc. View institutional ownership trends. How do I buy shares of QuidelOrtho? Shares of QDEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of QuidelOrtho own? Based on aggregate information from My MarketBeat watchlists, some other companies that QuidelOrtho investors own include NVIDIA (NVDA), Tesla (TSLA), Zoom Communications (ZM), Alibaba Group (BABA), Advanced Micro Devices (AMD), Block (XYZ) and Docusign (DOCU). Company Calendar Last Earnings11/03/2026Today11/15/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 10 days, QDEL's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Supplies Current SymbolNASDAQ:QDEL CIK1906324 Webwww.quidelortho.com Phone(858) 552-1100Fax858-453-4338Employees6,500Year Founded1979Price Target and Rating Average Price Target for QuidelOrtho$13.63 High Price Target$18.00 Low Price Target$12.00 Potential Upside/Downside+26.9%Consensus RatingReduce Rating Score (0-4)1.67 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($5.41) Trailing P/E RatioN/A Forward P/E Ratio8.14 P/E GrowthN/ANet Income-$1.13 billion Net Margins-14.24% Pretax Margin-12.96% Return on Equity3.22% Return on Assets1.03% Debt Debt-to-Equity Ratio1.40 Current Ratio1.36 Quick Ratio0.75 Sales & Book Value Annual Sales$2.73 billion Price / Sales0.27 Cash Flow$19.18 per share Price / Cash Flow0.56 Book Value$26.11 per share Price / Book0.41Miscellaneous Outstanding Shares68,610,000Free Float67,858,000Market Cap$736.87 million OptionableOptionable Beta0.77 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:QDEL) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredUnbelievable…Congress is About to Do What?Jim Rickards, former advisor to the CIA, the Pentagon and the White House, says a key turning point in Washing...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding QuidelOrtho Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share QuidelOrtho With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.